- Age at Diagnosis and the Risk of Diabetic Nephropathy in Young Patients with Type 1 Diabetes Mellitus
-
Baek JH, Lee WJ, Lee BW, Kim SK, Kim G, Jin SM, Kim JH
- KMID: 2507623
- Diabetes Metab J.
- 2020 Jul;44(S1):e36.
- doi: 10.4093/dmj.2019.0134
Background: The aim of this study was to evaluate characteristics and risk of diabetic complications according to age at diagnosis among young adults with type 1 diabetes mellitus (T1DM). Methods: A... -
- CITED
-
- Close
- SHARE
-
- Close
- Exploration of the developmental process of vasculogenic mimicry in canine inflammatory mammary carcinoma
-
Choi JS, Oh YI, Lee BW, Kim HW, Yoon BI
- KMID: 2503835
- J Biomed Transl Res.
- 2020 Jun;21(2):95-99.
- doi: 10.12729/jbtr.2020.21.2.095
Canine inflammatory mammary carcinoma (CIMC) similar to human inflammatory breast cancer is a very aggressive, metastatic type of cancer. Previous studies have introduced a new type of tumor angiogenesis called... -
- CITED
-
- Close
- SHARE
-
- Close
- Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
-
Lee BW, Lee Yh, Park CY, Rhee EJ, Lee WY, Kim NH, Choi KM, Park KG, Choi YK, Cha BS, Lee DH, on Behalf of The Korean Diabetes Association (KDA) Fatty Liver Research Group
- KMID: 2505891
- Diabetes Metab J.
- 2020 Jun;44(3):382-401.
- doi: 10.4093/dmj.2020.0010
This clinical practice position statement, a product of the Fatty Liver Research Group of the Korean Diabetes Association, proposes recommendations for the diagnosis, progression and/or severity assessment, management, and follow-up... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus
-
Lee H, Kim G, Choi YJ, Huh BW, Lee BW, Kang ES, Cha BS, Lee EJ, Lee Yh, Huh KB
- KMID: 2502408
- Diabetes Metab J.
- 2020 Apr;44(2):267-276.
- doi: 10.4093/dmj.2019.0001
Background: Impaired diastolic heart function has been observed in persons with non-alcoholic fatty liver disease (NAFLD) and/or with type 2 diabetes mellitus (T2DM). However, it is unclear whether NAFLD fibrotic... -
- CITED
-
- Close
- SHARE
-
- Close
- Data Configuration and Publication Trends for the Korean National Health Insurance and Health Insurance Review & Assessment Database
-
Kim HK, Song SO, Noh J, Jeong IK, Lee BW
- KMID: 2507692
- Diabetes Metab J.
- 2020 Oct;44(5):671-678.
- doi: 10.4093/dmj.2020.0207
Background: Big data reports related to diseases and health care for the Korean population have been published since the National Health Insurance Service (NHIS) and the Health Insurance Review &... -
- CITED
-
- Close
- SHARE
-
- Close
- Association Between Serum Bilirubin and the Progression of Carotid Atherosclerosis in Type 2 Diabetes
-
Lee I, Lee HH, Cho Y, Choi YJ, Huh BW, Lee BW, Kang ES, Park SW, Cha BS, Lee EJ, Lee YH, Huh KB
- KMID: 2470811
- J Lipid Atheroscler.
- 2020 Jan;9(1):195-204.
- doi: 10.12997/jla.2020.9.1.195
OBJECTIVE: This study investigated whether serum bilirubin levels can predict the progression of carotid atherosclerosis in individuals with type 2 diabetes mellitus (T2DM). METHODS: This observational study included 1,381 subjects with... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Management of Type 2 Diabetes Mellitus in Primary Care Clinics in Korea
-
Seo DH, Kang S, Lee YH, Ha JY, Park JS, Lee BW, Kang ES, Ahn CW, Cha BS
- KMID: 2458631
- Endocrinol Metab.
- 2019 Sep;34(3):282-290.
- doi: 10.3803/EnM.2019.34.3.282
BACKGROUND: This study investigated the overall status of diabetes control and screening for diabetic microvascular complications in patients with type 2 diabetes mellitus attending primary care clinics in Korea. METHODS: In... -
- CITED
-
- Close
- SHARE
-
- Close
- Trends in Hyperglycemic Crisis Hospitalizations and in- and out-of-Hospital Mortality in the Last Decade Based on Korean National Health Insurance Claims Data
-
You JH, Song SO, Park SH, Park KH, Nam JY, Kim DW, Kim HM, Kim DJ, Lee YH, Lee BW
- KMID: 2458630
- Endocrinol Metab.
- 2019 Sep;34(3):275-281.
- doi: 10.3803/EnM.2019.34.3.275
BACKGROUND: Hyperglycemic crisis is a metabolic emergency associated with diabetes mellitus. However, accurate epidemiologic information on cases of hyperglycemic crisis in Korea remains scarce. We evaluated trends in hyperglycemic crisis... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea
-
Kang YM, Jung CH, Lee SH, Kim SW, Song KH, Kim SG, Kim JH, Cho YM, Park TS, Ku BJ, Koh G, Kim DM, Lee BW, Park JY
- KMID: 2455667
- Diabetes Metab J.
- 2019 Aug;43(4):432-446.
- doi: 10.4093/dmj.2018.0092
BACKGROUND: We aimed to investigate the effectiveness and safety of adding basal insulin to initiating dipeptidyl peptidase-4 (DPP-4) inhibitor and metformin and/or sulfonylurea (SU) in achieving the target glycosylated hemoglobin... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness of Exercise Intervention in Reducing Body Weight and Glycosylated Hemoglobin Levels in Patients with Type 2 Diabetes Mellitus in Korea: A Systematic Review and Meta-Analysis
-
Jang JE, Cho Y, Lee BW, Shin ES, Lee SH
- KMID: 2454059
- Diabetes Metab J.
- 2019 Jun;43(3):302-318.
- doi: 10.4093/dmj.2018.0062
BACKGROUND: This study aimed to assess the effectiveness of exercise intervention in reducing body weight and glycosylated hemoglobin (HbA1c) level in patients with type 2 diabetes mellitus (T2DM) in Korea. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Acarbose Add-on Therapy in Patients with Type 2 Diabetes Mellitus with Metformin and Sitagliptin Failure: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
-
Yang HK, Lee SH, Shin J, Choi YH, Ahn YB, Lee BW, Rhee EJ, Min KW, Yoon KH
- KMID: 2454058
- Diabetes Metab J.
- 2019 Jun;43(3):287-301.
- doi: 10.4093/dmj.2018.0054
BACKGROUND: We evaluated the efficacy and safety of acarbose add-on therapy in Korean patients with type 2 diabetes mellitus (T2DM) who are inadequately controlled with metformin and sitagliptin. METHODS: A total... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors
-
Lee JY, Cho Y, Lee M, Kim YJ, Lee YH, Lee BW, Cha BS, Kang ES
- KMID: 2442769
- Diabetes Metab J.
- 2019 Apr;43(2):158-173.
- doi: 10.4093/dmj.2018.0057
BACKGROUND: We investigated the predictive markers for the therapeutic efficacy and the best combination of sodium-glucose co-transporter 2 (SGLT2) inhibitors (empagliflozin, dapagliflozin, and ipragliflozin) therapy in patients with type 2... -
- CITED
-
- Close
- SHARE
-
- Close
- Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment
-
Kim KS, Lee BW, Kim YJ, Lee DH, Cha BS, Park CY
- KMID: 2442766
- Diabetes Metab J.
- 2019 Apr;43(2):127-143.
- doi: 10.4093/dmj.2019.0034
Nonalcoholic fatty liver disease (NAFLD) and diabetes are common metabolic disorders that are often comorbid conditions. Among many proposed treatments, weight reduction is the only approved option for NAFLD to... -
- CITED
-
- Close
- SHARE
-
- Close
- Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
-
Lee YH, Cho Y, Lee BW, Park CY, Lee DH, Cha BS, Rhee EJ
- KMID: 2460970
- Diabetes Metab J.
- 2019 Feb;43(1):31-45.
- doi: 10.4093/dmj.2019.0011
Nonalcoholic fatty liver disease (NAFLD) and diabetes are common metabolic disorders whose prevalence rates are expected to rise worldwide, corresponding to aging and increasingly obese populations. Compared to the general... -
- CITED
-
- Close
- SHARE
-
- Close
- A Lower Baseline Urinary Glucose Excretion Predicts a Better Response to the Sodium Glucose Cotransporter 2 Inhibitor
-
Hwang YC, Kim JH, Lee BW, Lee WJ
- KMID: 2466510
- Diabetes Metab J.
- 2019 Dec;43(6):898-905.
- doi: 10.4093/dmj.2018.0257
We aimed to identify the clinical variables associated with a better glucose-lowering response to the sodium glucose cotransporter 2 inhibitor ipragliflozin in people with type 2 diabetes mellitus (T2DM). We... -
- CITED
-
- Close
- SHARE
-
- Close
- Corrigenda: Table Correction. Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
-
Lee YH, Cho Y, Lee BW, Park CY, Lee DH, Cha BS, Rhee EJ
- KMID: 2460967
- Diabetes Metab J.
- 2019 Oct;43(5):731-731.
- doi: 10.4093/dmj.2019.0188
In this article, the description of one equation named “NAFLD liver fat score†in the Table 3 was miswritten. -
- CITED
-
- Close
- SHARE
-
- Close
- Retrospective Genetic Analysis of 200 Cases of Sudden Infant Death Syndrome and Its Relationship with Long QT Syndrome in Korea
-
Son MJ, Kim MK, Yang KM, Choi BH, Lee BW, Yoo SH
- KMID: 2417914
- J Korean Med Sci.
- 2018 Aug;33(32):e200.
- doi: 10.3346/jkms.2018.33.e200
BACKGROUND: There has been a campaign by the National Education on Sleeping Habits and Living Environment, to reduce the incidence of sudden infant death syndrome (SIDS). However, more than 100... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the Effects of Ezetimibe-Statin Combination Therapy on Major Adverse Cardiovascular Events in Patients with and without Diabetes: A Meta-Analysis
-
Hong N, Lee YH, Tsujita K, Gonzalez J, Kramer CM, Kovarnik T, Kouvelos G, Suzuki H, Han K, Lee CJ, Park SH, Lee BW, Cha BS, Kang ES
- KMID: 2420490
- Endocrinol Metab.
- 2018 Jun;33(2):219-227.
- doi: 10.3803/EnM.2018.33.2.219
BACKGROUND: Ezetimibe-statin combination therapy has been found to reduce low density lipoprotein cholesterol levels and the risk of major adverse cardiovascular events (MACEs) in large trials. We sought to examine... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of Patients with Nonalcoholic Fatty Liver Disease with Lifestyle Modification
-
Lee BW
- KMID: 2415851
- J Korean Diabetes.
- 2018 Jun;19(2):82-87.
- doi: 10.4093/jkd.2018.19.2.82
In the management and treatment of nonalcoholic fatty liver disease (NAFLD) ranging from hepatic steatosis (HS) to nonalcoholic steatohepatitis (NASH), the goals in patients without NASH or hepatic fibrosis are... -
- CITED
-
- Close
- SHARE
-
- Close
- Glycated Albumin Is a More Useful Glycation Index than HbA1c for Reflecting Renal Tubulopathy in Subjects with Early Diabetic Kidney Disease
-
Huh JH, Lee M, Park SY, Kim JH, Lee BW
- KMID: 2413984
- Diabetes Metab J.
- 2018 Jun;42(3):215-223.
- doi: 10.4093/dmj.2017.0091
BACKGROUND: The aim of this study was to investigate which glycemic parameters better reflect urinary N-acetyl-β-D-glucosaminidase (uNAG) abnormality, a marker for renal tubulopathy, in subjects with type 2 diabetes mellitus... -
- CITED
-
- Close
- SHARE
-
- Close
